Evidence map›Paper›PMID 34376217›Full record

ArticleAlgorithms for molecular biology : AMB2021

INGOT-DR: an interpretable classifier for predicting drug resistance in M. tuberculosis.

Hooman Zabeti, Nick Dexter, Amir Hosein Safari, Nafiseh Sedaghat, Maxwell Libbrecht, Leonid Chindelevitch

Abstract read
In one paragraph

Article in Algorithms for molecular biology : AMB, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. The 2021 WHO catalogue ofThe Lancet. Microbe · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hooman ZabetiSchool of Computing Science, Simon Fraser University, Burnaby, Canada. hooman_zabeti@sfu.ca.
Nick DexterDepartment of Mathematics, Simon Fraser University, Burnaby, Canada.
Amir Hosein SafariSchool of Computing Science, Simon Fraser University, Burnaby, Canada.
Nafiseh SedaghatSchool of Computing Science, Simon Fraser University, Burnaby, Canada.
Maxwell LibbrechtSchool of Computing Science, Simon Fraser University, Burnaby, Canada.
Leonid ChindelevitchDepartment of Infectious Disease Epidemiology, Imperial College, London, UK.ORCID http://orcid.org/0000-0002-6619-6013

Funding

Foreign and Commonwealth Office (GB) MR/R015600/1Genome Canada (CA) BAC283Medical Research Council MR/R015600/1Medical Research Council (GB) MR/R015600/1
6 · The paper itself

Abstract

motivationPrediction of drug resistance and identification of its mechanisms in bacteria such as Mycobacterium tuberculosis, the etiological agent of tuberculosis, is a challenging problem. Solving this problem requires a transparent, accurate, and flexible predictive model. The methods currently used for this purpose rarely satisfy all of these criteria. On the one hand, approaches based on testing strains against a catalogue of previously identified mutations often yield poor predictive performance; on the other hand, machine learning techniques typically have higher predictive accuracy, but often lack interpretability and may learn patterns that produce accurate predictions for the wrong reasons. Current interpretable methods may either exhibit a lower accuracy or lack the flexibility needed to generalize them to previously unseen data. CONTRIBUTION: In this paper we propose a novel technique, inspired by group testing and Boolean compressed sensing, which yields highly accurate predictions, interpretable results, and is flexible enough to be optimized for various evaluation metrics at the same time.

resultsWe test the predictive accuracy of our approach on five first-line and seven second-line antibiotics used for treating tuberculosis. We find that it has a higher or comparable accuracy to that of commonly used machine learning models, and is able to identify variants in genes with previously reported association to drug resistance. Our method is intrinsically interpretable, and can be customized for different evaluation metrics. Our implementation is available at github.com/hoomanzabeti/INGOT_DR and can be installed via The Python Package Index (Pypi) under ingotdr. This package is also compatible with most of the tools in the Scikit-learn machine learning library.

Indexed as

Drug resistanceGroup testingInteger linear programmingInterpretable machine learningRule-based learningWhole-genome sequencing

Identifiers

PMID34376217
PMCPMC8353837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.